Trial Profile
Rho kinase in patients with atherosclerosis: effects of statins- a double blind, randomized clinical trial comparing rosuvastatin and atorvastatin
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Rosuvastatin (Primary)
- Indications Atherosclerosis; Myocardial infarction; Peripheral arterial disorders; Stroke
- Focus Pharmacodynamics
- 18 Dec 2005 New trial record.